| 000 | 01691 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517095611.0 | ||
| 264 | 0 | _c20170613 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1872-7972 | ||
| 024 | 7 |
_a10.1016/j.neulet.2016.05.040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKheradmand, Afshin | |
| 245 | 0 | 0 |
_aEffects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines. _h[electronic resource] |
| 260 |
_bNeuroscience letters _c08 2016 |
||
| 300 |
_a7-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGlutathione _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-1beta _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aMercaptoethylamines _xadministration & dosage |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aPars Compacta _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xcerebrospinal fluid |
| 700 | 1 | _aNayebi, Alireza M | |
| 700 | 1 | _aJorjani, Masoumeh | |
| 700 | 1 | _aKhalifeh, Solmaz | |
| 700 | 1 | _aHaddadi, Rasool | |
| 773 | 0 |
_tNeuroscience letters _gvol. 627 _gp. 7-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neulet.2016.05.040 _zAvailable from publisher's website |
| 999 |
_c26056721 _d26056721 |
||